Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Study to Compare the Efficacy and Safety of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes (ACS) undergoing Percutaneous Coronary Interventions (PCI)

Next Previous
Trial Profile

A Study to Compare the Efficacy and Safety of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes (ACS) undergoing Percutaneous Coronary Interventions (PCI)

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Mar 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Prasugrel (Primary) ; Clopidogrel
  • Indications Acute coronary syndromes; Myocardial infarction; Stroke
  • Focus Adverse reactions
  • Acronyms PROMETHEUS
  • Sponsors Daiichi Sankyo Inc; Eli Lilly and Company

Most Recent Events

  • 02 Nov 2017 Results assessing the association between Stent Diameter and Clinical Outcomes in patients treated with second generation drug eluting stents (n=12527) presented at the 29th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics
  • 02 Nov 2017 Results assessing the association between stent length and clinical events in patients treated with second generation DES (n=12437) presented at the 29th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics
  • 30 Aug 2017 Results assessing influence of history of cerebrovascular disease on physicians' treatment choices and clinical outcomes after percutaneous coronary interventions presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top